Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |